Scientists from the VA North Texas Health Care System found that for people with diabetes, statin initiation is linked to diabetes development.
They examined diabetes progression after statin initiation among patients with diabetes.
In the study, the team used data from patients aged 30 years or older who initiated treatment with statins (statin users) or with H2-blockers or proton pump inhibitors (active comparators); 83,022 pairs of statin users and active comparators were tested.
The researchers found that the diabetes progression outcome (new insulin initiation, increase in the number of glucose-lowering medication classes, the incidence of five or more measurements of blood glucose of 200 mg/dL or greater, or a new diagnosis of ketoacidosis or uncontrolled diabetes) occurred in 55.9% and 48.0% of statin users and active comparators, respectively.
In another analysis, the team found a dose-response link, with a higher intensity of low-density lipoprotein cholesterol-lowering linked to a greater progression of diabetes.
The researchers suggest that further research is needed to form a risk-tailored approach to balancing the cardiovascular benefits of statin therapy with its risk of diabetes progression.
If you care about diabetes, please read studies about surgery that can be a ‘cure’ for type 2 diabetes, and this diet can help manage blood sugar.
For more information about diabetes, please see recent studies about a promising new way to treat type 2 diabetes, and results showing eggs for breakfast may benefit people with diabetes.
The research was published in JAMA Internal Medicine and conducted by Ishak A. Mansi et al.
Copyright © 2022 Knowridge Science Report. All rights reserved.
